Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 200 participants.
Also called NCT03021928
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 200 participants
- Registry
-
NCT03021928
-
- Other papers using this trial's data
- Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Unknown status
Technical summary
Registry record NCT03021928. Randomized; single masking; primary purpose prevention. Start 2017-06-14 (actual); primary completion 2023-08-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation
- Acronym
- START
- Condition
- Stroke
- Intervention (Other)
- Time-To-Treatment Randomization
- Lead sponsor
- University of Texas at Austin
- Collaborator
- Lone Star Stroke Research Consortium
- Collaborator
- Texas Department of State Health Services
Record details
- Record id
cardio:ct-nct03021928- Content hash
5f2eeb499509346830f4143f52306d41d4c1182efce746f341ab39115998c52a